Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W1965410373', 'doi': 'https://doi.org/10.4062/biomolther.2009.17.3.311', 'title': 'Negligible Effect of Ginkgo Biloba Extract on the Pharmacokinetics of Cilostazol', 'display_name': 'Negligible Effect of Ginkgo Biloba Extract on the Pharmacokinetics of Cilostazol', 'publication_year': 2009, 'publication_date': '2009-07-31', 'ids': {'openalex': 'https://openalex.org/W1965410373', 'doi': 'https://doi.org/10.4062/biomolther.2009.17.3.311', 'mag': '1965410373'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.4062/biomolther.2009.17.3.311', 'pdf_url': 'http://koreascience.or.kr:80/article/JAKO200922335514871.pdf', 'source': {'id': 'https://openalex.org/S2593996', 'display_name': 'Biomolecules & Therapeutics', 'issn_l': '1976-9148', 'issn': ['1976-9148', '2005-4483'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4362643885', 'host_organization_name': 'Korean Society of Applied Pharmacology', 'host_organization_lineage': ['https://openalex.org/P4362643885'], 'host_organization_lineage_names': ['Korean Society of Applied Pharmacology'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'http://koreascience.or.kr:80/article/JAKO200922335514871.pdf', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5076039392', 'display_name': 'Hye Jin Chung', 'orcid': 'https://orcid.org/0000-0003-2274-6607'}, 'institutions': [{'id': 'https://openalex.org/I58716616', 'display_name': 'Korea Institute of Science and Technology', 'ror': 'https://ror.org/05kzfa883', 'country_code': 'KR', 'type': 'facility', 'lineage': ['https://openalex.org/I58716616']}], 'countries': ['KR'], 'is_corresponding': False, 'raw_author_name': 'Hye-Jin Chung', 'raw_affiliation_strings': ['Center for Chemoinformatics Research, Korea Institute of Science and Technology,'], 'affiliations': [{'raw_affiliation_string': 'Center for Chemoinformatics Research, Korea Institute of Science and Technology,', 'institution_ids': ['https://openalex.org/I58716616']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5108383886', 'display_name': 'Nam-Sun Kim', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I58716616', 'display_name': 'Korea Institute of Science and Technology', 'ror': 'https://ror.org/05kzfa883', 'country_code': 'KR', 'type': 'facility', 'lineage': ['https://openalex.org/I58716616']}], 'countries': ['KR'], 'is_corresponding': False, 'raw_author_name': 'Nam-Sun Kim', 'raw_affiliation_strings': ['Doping Control Center, Korea Institute of Science and Technology, Seoul 130-650,'], 'affiliations': [{'raw_affiliation_string': 'Doping Control Center, Korea Institute of Science and Technology, Seoul 130-650,', 'institution_ids': ['https://openalex.org/I58716616']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100667223', 'display_name': 'Eun Jeong Kim', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I134353371', 'display_name': 'SK Group (South Korea)', 'ror': 'https://ror.org/03696td91', 'country_code': 'KR', 'type': 'company', 'lineage': ['https://openalex.org/I134353371']}], 'countries': ['KR'], 'is_corresponding': False, 'raw_author_name': 'Eun-Jeong Kim', 'raw_affiliation_strings': ['Life Science R&D Center, SK Chemicals, Suwon 440-300, Republic of Korea'], 'affiliations': [{'raw_affiliation_string': 'Life Science R&D Center, SK Chemicals, Suwon 440-300, Republic of Korea', 'institution_ids': ['https://openalex.org/I134353371']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102107601', 'display_name': 'Tae-Kon Kim', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Tae-Kon Kim', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5109890772', 'display_name': 'Keun-Ho Ryu', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I134353371', 'display_name': 'SK Group (South Korea)', 'ror': 'https://ror.org/03696td91', 'country_code': 'KR', 'type': 'company', 'lineage': ['https://openalex.org/I134353371']}], 'countries': ['KR'], 'is_corresponding': False, 'raw_author_name': 'Keun-Ho Ryu', 'raw_affiliation_strings': ['Life Science R&D Center, SK Chemicals, Suwon 440-300, Republic of Korea'], 'affiliations': [{'raw_affiliation_string': 'Life Science R&D Center, SK Chemicals, Suwon 440-300, Republic of Korea', 'institution_ids': ['https://openalex.org/I134353371']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5056769099', 'display_name': 'Bongyong Lee', 'orcid': 'https://orcid.org/0000-0003-3134-7093'}, 'institutions': [{'id': 'https://openalex.org/I134353371', 'display_name': 'SK Group (South Korea)', 'ror': 'https://ror.org/03696td91', 'country_code': 'KR', 'type': 'company', 'lineage': ['https://openalex.org/I134353371']}], 'countries': ['KR'], 'is_corresponding': False, 'raw_author_name': 'Bong-Yong Lee', 'raw_affiliation_strings': ['Life Science R&D Center, SK Chemicals, Suwon 440-300, Republic of Korea'], 'affiliations': [{'raw_affiliation_string': 'Life Science R&D Center, SK Chemicals, Suwon 440-300, Republic of Korea', 'institution_ids': ['https://openalex.org/I134353371']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100454659', 'display_name': 'Dong‐Hyun Kim', 'orcid': 'https://orcid.org/0000-0001-9807-4064'}, 'institutions': [{'id': 'https://openalex.org/I58716616', 'display_name': 'Korea Institute of Science and Technology', 'ror': 'https://ror.org/05kzfa883', 'country_code': 'KR', 'type': 'facility', 'lineage': ['https://openalex.org/I58716616']}], 'countries': ['KR'], 'is_corresponding': False, 'raw_author_name': 'Dong-Hyun Kim', 'raw_affiliation_strings': ['Doping Control Center, Korea Institute of Science and Technology, Seoul 130-650,'], 'affiliations': [{'raw_affiliation_string': 'Doping Control Center, Korea Institute of Science and Technology, Seoul 130-650,', 'institution_ids': ['https://openalex.org/I58716616']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5031956506', 'display_name': 'Changbae Jin', 'orcid': 'https://orcid.org/0000-0002-4783-7671'}, 'institutions': [{'id': 'https://openalex.org/I58716616', 'display_name': 'Korea Institute of Science and Technology', 'ror': 'https://ror.org/05kzfa883', 'country_code': 'KR', 'type': 'facility', 'lineage': ['https://openalex.org/I58716616']}, {'id': 'https://openalex.org/I134353371', 'display_name': 'SK Group (South Korea)', 'ror': 'https://ror.org/03696td91', 'country_code': 'KR', 'type': 'company', 'lineage': ['https://openalex.org/I134353371']}], 'countries': ['KR'], 'is_corresponding': False, 'raw_author_name': 'Chang-Bae Jin', 'raw_affiliation_strings': ['Doping Control Center, Korea Institute of Science and Technology, Seoul 130-650,', 'Life Science R&D Center, SK Chemicals, Suwon 440-300, Republic of Korea'], 'affiliations': [{'raw_affiliation_string': 'Doping Control Center, Korea Institute of Science and Technology, Seoul 130-650,', 'institution_ids': ['https://openalex.org/I58716616']}, {'raw_affiliation_string': 'Life Science R&D Center, SK Chemicals, Suwon 440-300, Republic of Korea', 'institution_ids': ['https://openalex.org/I134353371']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5068541222', 'display_name': 'Hye Hyun Yoo', 'orcid': 'https://orcid.org/0000-0001-8282-852X'}, 'institutions': [{'id': 'https://openalex.org/I58716616', 'display_name': 'Korea Institute of Science and Technology', 'ror': 'https://ror.org/05kzfa883', 'country_code': 'KR', 'type': 'facility', 'lineage': ['https://openalex.org/I58716616']}], 'countries': ['KR'], 'is_corresponding': False, 'raw_author_name': 'Hye-Hyun Yoo', 'raw_affiliation_strings': ['Doping Control Center, Korea Institute of Science and Technology, Seoul 130-650,'], 'affiliations': [{'raw_affiliation_string': 'Doping Control Center, Korea Institute of Science and Technology, Seoul 130-650,', 'institution_ids': ['https://openalex.org/I58716616']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 2, 'citation_normalized_percentile': {'value': 0.796177, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 71, 'max': 74}, 'biblio': {'volume': '17', 'issue': '3', 'first_page': '311', 'last_page': '317'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12846', 'display_name': 'Ginkgo biloba and Cashew Applications', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2707', 'display_name': 'Complementary and alternative medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12846', 'display_name': 'Ginkgo biloba and Cashew Applications', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2707', 'display_name': 'Complementary and alternative medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T14144', 'display_name': 'Neurological Disease Mechanisms and Treatments', 'score': 0.9462, 'subfield': {'id': 'https://openalex.org/subfields/2808', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10085', 'display_name': "Parkinson's Disease Mechanisms and Treatments", 'score': 0.9244, 'subfield': {'id': 'https://openalex.org/subfields/2728', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/cilostazol', 'display_name': 'Cilostazol', 'score': 0.94099903}], 'concepts': [{'id': 'https://openalex.org/C2778998842', 'wikidata': 'https://www.wikidata.org/wiki/Q43284', 'display_name': 'Ginkgo biloba', 'level': 2, 'score': 0.9777592}, {'id': 'https://openalex.org/C2779820409', 'wikidata': 'https://www.wikidata.org/wiki/Q258591', 'display_name': 'Cilostazol', 'level': 3, 'score': 0.94099903}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.8184221}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.728707}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.54311293}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.32977903}, {'id': 'https://openalex.org/C2777628954', 'wikidata': 'https://www.wikidata.org/wiki/Q18216', 'display_name': 'Aspirin', 'level': 2, 'score': 0.24563435}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.13944158}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.4062/biomolther.2009.17.3.311', 'pdf_url': 'http://koreascience.or.kr:80/article/JAKO200922335514871.pdf', 'source': {'id': 'https://openalex.org/S2593996', 'display_name': 'Biomolecules & Therapeutics', 'issn_l': '1976-9148', 'issn': ['1976-9148', '2005-4483'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4362643885', 'host_organization_name': 'Korean Society of Applied Pharmacology', 'host_organization_lineage': ['https://openalex.org/P4362643885'], 'host_organization_lineage_names': ['Korean Society of Applied Pharmacology'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.4062/biomolther.2009.17.3.311', 'pdf_url': 'http://koreascience.or.kr:80/article/JAKO200922335514871.pdf', 'source': {'id': 'https://openalex.org/S2593996', 'display_name': 'Biomolecules & Therapeutics', 'issn_l': '1976-9148', 'issn': ['1976-9148', '2005-4483'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4362643885', 'host_organization_name': 'Korean Society of Applied Pharmacology', 'host_organization_lineage': ['https://openalex.org/P4362643885'], 'host_organization_lineage_names': ['Korean Society of Applied Pharmacology'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'score': 0.66, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 31, 'referenced_works': ['https://openalex.org/W1497221593', 'https://openalex.org/W1828403552', 'https://openalex.org/W1978015759', 'https://openalex.org/W1980474768', 'https://openalex.org/W1997849419', 'https://openalex.org/W1999727213', 'https://openalex.org/W2000261986', 'https://openalex.org/W2005325031', 'https://openalex.org/W2005750416', 'https://openalex.org/W2011707100', 'https://openalex.org/W2019611014', 'https://openalex.org/W2037506783', 'https://openalex.org/W2040854616', 'https://openalex.org/W2049462732', 'https://openalex.org/W2049701261', 'https://openalex.org/W2058417929', 'https://openalex.org/W2060004662', 'https://openalex.org/W2062117918', 'https://openalex.org/W2062626127', 'https://openalex.org/W2066806870', 'https://openalex.org/W2067384349', 'https://openalex.org/W2074299694', 'https://openalex.org/W2089535392', 'https://openalex.org/W2147041834', 'https://openalex.org/W2149328140', 'https://openalex.org/W22433965', 'https://openalex.org/W2341539444', 'https://openalex.org/W2414048420', 'https://openalex.org/W4089902', 'https://openalex.org/W4252822777', 'https://openalex.org/W4255398729'], 'related_works': ['https://openalex.org/W4364376666', 'https://openalex.org/W3043458966', 'https://openalex.org/W2960553615', 'https://openalex.org/W2748952813', 'https://openalex.org/W2375231045', 'https://openalex.org/W2361082614', 'https://openalex.org/W2181051065', 'https://openalex.org/W2162491061', 'https://openalex.org/W2141289501', 'https://openalex.org/W1965410373'], 'abstract_inverted_index': {'Ginkgo': [0], 'biloba': [1, 44, 75, 84, 112, 125, 144, 179, 220], '(G.': [2], 'biloba)': [3], 'extract': [4, 45, 76, 85, 113, 126, 145, 180, 221], 'is': [5, 19, 38, 95], 'a': [6, 20, 57, 215], 'widely': [7], 'used': [8], 'phytomedicine': [9], 'for': [10, 26, 48, 200], 'the': [11, 27, 49, 79, 82, 87, 108, 115, 121, 128, 135, 157, 172, 177, 186, 201], 'oral': [12], 'treatment': [13, 28, 50], 'of': [14, 29, 51, 59, 64, 81, 89, 110, 123, 130, 134, 165, 188, 203], 'peripheral': [15, 34, 52], 'vascular': [16], 'disease.': [17, 36], 'Cilostazol': [18], 'synthetic': [21], 'antiplatelet': [22], 'and': [23, 46, 77, 120, 152, 168, 222], 'vasodilating': [24], 'agent': [25], 'intermittent': [30], 'claudication': [31], 'resulting': [32], 'from': [33], 'arterial': [35, 53], 'It': [37], 'likely': [39], 'to': [40, 97, 138, 197], 'use': [41], 'concomitantly': [42], 'G.': [43, 74, 83, 111, 124, 143, 178, 219], 'cilostazol': [47, 90, 94, 131, 189], 'disease,': [54], 'which': [55], 'raises': [56], 'concern': [58], 'increasing': [60], 'their': [61], 'adverse': [62], 'effects': [63, 109], 'herbal-drug': [65, 71], 'interactions.': [66], 'To': [67], 'clarify': [68], 'any': [69], 'possible': [70], 'interaction': [72, 217], 'between': [73, 218], 'cilostazol,': [78], 'effect': [80, 122, 184], 'on': [86, 114, 127, 185], 'pharmacokinetics': [88, 129, 187], 'was': [91], 'investigated.': [92], 'As': [93], 'known': [96], 'be': [98, 198, 214], 'eliminated': [99], 'mainly': [100], 'by': [101], 'cytochrome': [102], 'P450': [103], '(CYP)-mediated': [104], 'metabolism,': [105], 'we': [106], 'investigated': [107], 'human': [116], 'CYP': [117], 'enzyme': [118, 154], 'activities': [119, 155], 'after': [132], 'co-administration': [133, 175], 'two': [136], 'agents': [137], 'male': [139], 'beagle': [140], 'dogs.': [141], 'The': [142], 'inhibited': [146], 'more': [147], 'or': [148], 'less': [149], 'CYP2C8,': [150], 'CYP2C9,': [151], 'CYP2C19': [153], 'in': [156, 158, 190], 'vitro': [159], 'microsomal': [160], 'study': [161], 'with': [162, 176], '<TEX>$IC_{50}$</TEX>': [163], 'values': [164], '30.8,': [166], '60.5,': [167], '<TEX>$25.2{\\mu}g/ml$</TEX>,': [169], 'respectively.': [170], 'In': [171, 205], 'pharmacokinetic': [173, 216], 'study,': [174], 'had': [181], 'no': [182], 'significant': [183], 'dogs,': [191], 'although': [192], 'CYP2C': [193], 'has': [194], 'been': [195], 'reported': [196], 'responsible': [199], 'metabolism': [202], 'cilostazol.': [204, 223], 'conclusion,': [206], 'these': [207], 'results': [208], 'suggest': [209], 'that': [210], 'there': [211], 'may': [212], 'not': [213]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1965410373', 'counts_by_year': [{'year': 2021, 'cited_by_count': 1}, {'year': 2018, 'cited_by_count': 1}], 'updated_date': '2024-12-24T16:10:01.272572', 'created_date': '2016-06-24'}